Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition

16:42 EDT 28 May 2018 | Nature Publishing

More From BioPortfolio on "Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition"